Intelligent Bio Solutions to Participate in the LD Micro Invitational XIII on June 6th
Intelligent Bio Solutions has announced that management will be participating in the LD Micro Invitational XIII in Los Angeles, June 6-8, 2023.
Intelligent Bio Solutions Plans to Add Fentanyl Testing as it Further Enhances its Fingerprint-Based Drug Screening Solution
Lab-testing pathway to expand capabilities of proprietary drug test screening to detect potent opioid fentanyl and fentanyl-adulterated street drugs.
INTELLIGENT BIO SOLUTIONS INC. REPORTS FISCAL 2023 THIRD QUARTER FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
Intelligent Bio Solutions Inc. today announced its financial results for its fiscal third quarter ended March 31, 2023, and provided a business update.
Intelligent Bio Solutions Scales Reach Throughout Asia-Pacific Region with Addition of Sales Team in Australia, New Distribution Hub and Office Facility
Intelligent Bio Solutions Inc. announces the recruitment of four highly experienced sales executives from across the workplace safety and supply, manufacturing, and the drugs and alcohol testing industries for its new sales force in Australia.
UK Food Processing Equipment Manufacturer Latest to Adopt Intelligent Bio Solutions’ Portable Fingerprint Drug Testing Solution
Dodman Limited, specialists in the design, manufacture, installation and maintenance of processing systems for major food manufacturers, has selected our Intelligent Fingerprinting Drug Screening System to support random and for cause drug testing activities across its operations over traditional urine tests.
Intelligent Bio Solutions Secures UK Patent for Intelligent Fingerprinting DSR-Plus Cartridge Reader
Intelligent Bio Solutions has been granted a patent in the United Kingdom (UK) relating to its Intelligent Fingerprinting Drug Screening System DSR-Plus Cartridge Reader. This is the Company’s 13th patent.
A&F Sprinklers Selects Intelligent Bio Solutions’ Latest DSR-Plus Screening Unit to Support its Random Drug Screening Program
A & F Sprinklers, one of the UK’s leading fire protection and automatic sprinkler systems specialists, has selected Intelligent Bio Solutions’ Intelligent Fingerprinting Drug Screening System to support its random drug testing activities across its operations.
Intelligent Bio Solutions Selects HASTA Laboratory as Drug Testing Specialist in Australia
Intelligent Bio Solutions has selected Human and Supplement Testing Australia (“HASTA”), Australia’s largest independent sports drug testing laboratory, as its preferred drug testing specialist in Australia to complete lab-based confirmation testing for its Intelligent Fingerprinting System.
Intelligent Bio Solutions Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants
Intelligent Bio Solutions today announced the closing of its previously announced underwritten public offering. Ladenburg Thalmann & Co. Inc. acted as the sole bookrunning manager for the offering.
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering NEW YORK, NY, March 8, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced the pricing of its previously announced underwritten public offering of 569,560 shares […]